DAY 1
Central and South-East European Melanoma Expert Group (CSEEMEG) regional meeting.
| PRVI DAN / DAY 1 | 26.11.2020. | |
|---|---|---|
| 09.30 - 09.40 | Opening of the meeting | Prof. dr Mirna Šitum, Doc. dr Davorin Herceg dr.med, Prof. dr Lidija Kandolf Sekulović |
| 09.40 - 10.10 | Opening lecture: Melanoma 2020: State of the art in the treatment of metastatic disease | Prof. dr med. Axel Hauschild (Germany) |
| 10.10 - 10.25 | Discussion | |
| 10.25 - 11.30 | Special clinical scenarios and best treatment options (with discussion) | Moderators: Prof. dr med. Axel Hauschild, Prof. dr Lidija Kandolf Sekulović, Doc. dr. Davorin Herceg dr.med, Assoc. Professor Janja Ocvirk |
| 10.30 - 10.40 | Patient with oligometastatic disease. Luka Simetić (Croatia) | Luka Simetić (Croatia) |
| 10.40 - 10.50 | Patient with progression to targeted therapy | Prof. dr Željko Mijušković (Serbia) |
| 10.50 - 11.00 | BRAFwt metastatic melanoma with progression on anti-PD1 monotherapy | Prof. dr Janja Ocvirk (Slovenia) |
| 11.00 - 11.10 | Patient with asymptomatic brain metastases | Doc. dr Davorin Herceg (Croatia) |
| 11.10 - 11.20 | Patient with symptomatic brain metastases | Prim. dr sc. Nina Dabelić (Croatia) |
| 11.20 - 11.30 | Discussion | |
| 11.30 - 12.00 | ||
| 12.00 - 13.00 | ||
| 13.00 - 14.30 | Special clinical scenarios and best treatment options (with discussion) | Moderators: Prof.dr Nada Babović Prof. dr Janja Ocvirk Academician Prof. dr Mirna Šitum |
| 13.05 - 13.09 | Patient with bone metastases | Dr sc. med Vladimir Vidović (Serbia) |
| 13.09 - 13.14 | Patient with progression on second-line treatment | Dr Aleksandar Popović (Serbia) |
| 13.14 - 13.24 | Patients with autoimmune diseases and chronic infections | Dr Dobrica Nerić (Serbia) |
| 13.24 - 13.34 | Patient with grade 3 adverse reaction to immunotherapy. | Dr Suzana Matković (Serbia) |
| 13.34 - 13.43 | Patient with grade 3 cutaneous toxicity to targeted therapy: Stevens-Johnson syndrome and TEN. | Doc. dr Tatjana Radević (Serbia) |
| 13.43 - 14.53 | Patient with grade 3 cutaneous toxicity to immunotherapy | Prof. dr Dušan Škiljević (Serbia) |
| 13.53 - 14.00 | Patient with vitiligo | Prim. dr sc. Daška Štulhofer Buzina (Croatia) |
| 14.00 - 14.10 | Patient with changing melanocytic lesions during treatment. | Doc. dr sc. Marija Buljan (Croatia) |
| 14.10 - 14.30 | Discussion | All participants |
| 14.30 - 15.40 | ||
| 15.40 - 16.00 | Pause | |
| 16.00 - 17.00 | EuMelaReg and CSEEREG melanoma treatment registries - first results | Moderators: Academician prof. dr. Mirna Šitum, Doc. dr. Davorin Herceg, Prof. dr Lidija Kandolf Sekulović |
| 16.00 - 16.15 | The EuMelaReg treatment registry | Prof. dr Michael Weichenthal (Germany) |
| 16.15 - 16.30 | CSEEREG: review of the registry | Academician prof. dr. Mirna Šitum (Croatia) |
| 16.30 - 16.50 | Treatment and outcomes in stage III and stage IV disease: first results from CSEEREG | Doc. dr. Davorin Herceg (Croatia) and Prof. dr Lidija Kandolf Sekulović |
| 16.50 - 17.00 | Conclusions | All participants |